Greece’s Health Minister Thanos Plevris announced plans to sue Novartis over what he alleges are illegal practices. The scandal has been playing out for several years, with Novartis alleged to have paid Greek public officials and health care providers to increase prescriptions for the company’s drugs and maintain higher prices.
Moderna is facing additional challenges to patent the COVID-19 vaccine Spikevax, as Arbutus Biopharma and Genevant filed a lawsuit against the company challenging patent infringement.
The Sackler family owners of Purdue Pharma LP proposed a new and larger settlement worth up to $6 billion to resolve allegations that the OxyContin maker and the company’s owners contributed to the deadly U.S. opioid epidemic, a mediator’s report showed on February 18.
A federal judge on February 16 dismissed a proposed class action lawsuit by consumers who accused Pfizer Inc. of failing to disclose the presence of cancer-causing agents in Chantix before recalling the anti-smoking drug.
After allegations of bullying became public, Dr. Eric Lander – the director of the federal government’s Office of Science and Technology Policy – resigned from his executive branch role.
AstraZeneca agreed to pay a $560,000 settlement to resolve allegations of gender and racial discrimination filed by employees at the company’s Wilmington, Del. headquarters.
As the fraud trial of Theranos founder Elizabeth Holmes headlines the pharma legal news, other court-related cases are taking place, including a ruling in the legal spat between Takeda and AbbVie over a supply agreement for the prostate cancer drug Lupron.
St. Jude Medical, which was acquired by Abbott Laboratories in 2017, agreed to pay $27 million to settle allegations the company knowingly sold defective heart devices, the U.S. Justice Department said on July 8.
Moncef Slaoui, who served as chief scientist for the Operation Warp Speed response to the Covid-19 pandemic under former President Donald Trump, was fired as chairman of the board of directors of Galvani Bioelectronics following the “substantiation” of allegations of sexual harassment and inappropriate conduct.
A U.S. judge granted a Reuters request to unseal Merck & Co. documents produced in lawsuits related to the company’s anti-baldness treatment Propecia, finding that the public’s right to access outweighed the drug maker’s arguments for keeping the information secret.